By J. Walden, H. Grunze
Complement factor: Neuropsychobiology 2002, Vol. forty five, Suppl. 1
Read Online or Download Bipolar Disorders: 2nd Stanley Symposium, Freiburg, November 2000 (Neuropsychobiology) PDF
Best biophysics books
One of many Civil War's such a lot profitable generals is heralded via army historians yet by no means completed the lasting reputation of supply, Lee, Jackson or Sherman. George Thomas's Southern delivery, the ambition of fellow officials, and his motion within the less-publicized Western Theater mixed to maintain him from achieving reputation.
This ebook describes the cutting-edge of therapy of schizophrenia and displays its improvement in 22 chapters written by way of top gurus within the box
Additional info for Bipolar Disorders: 2nd Stanley Symposium, Freiburg, November 2000 (Neuropsychobiology)
The detailed documentation of the medication offers the possibility to find the right medication earlier. The graphical character of the forms used to register the data allows a direct interpretation, by the clinician as well as by the patient. Furthermore, the participation of the patient may contribute to a more stable and cooperative therapeutic alliance between him/her and the clinician and result in the patient’s active involvement in the management of his/her disorder. The Social Rhythm Metric An established diagnosis-specific psychotherapy for bipolar disorder is not available yet.
A disadvantage is the presentation of the data. Scores have to be processed graphically to be interpretable, especially for the patient. Documentation of medication, life events, comorbidity and clinician ratings is not included; the latter would probably enhance the validity of rating in the manic spectrum of bipolar disorder. The clear advantage of the Social Rhythm Metric is of course its direct psychotherapeutic usability. It is kind of really working with the registered data, but it neglects also the important aspects of medication, co-morbidity and life events.
11 Leppig M, Bosch B, Naber D, Hippius H: Clozapine in the treatment of 121 out-patients. Psychopharmacology (Berl) 1989;99(suppl): S77–S79. Neuropsychobiology 2002;45(suppl 1):37–42 12 Naber D, Leppig M, Grohmann R, Hippius H: Efficacy and adverse effects of clozapine in the treatment of schizophrenia and tardive dyskinesia – A retrospective study of 387 patients. Psychopharmacology (Berl) 1989;99(suppl): S73–S76. 13 Tohen M, Zarate CA: Antipsychotic agents and bipolar disorder. J Clin Psychiatry 1998; 59(suppl 1):S38–S48.